Nine Masts Capital’s Biomea Fusion BMEA Stock Holding History

Nine Masts Capital’s Portfolio BMEA Stock Details BMEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,472	Closed	-$49.7K	–	186
2026 Q1	$49.7K	Buy	+32,472	New	+$42.7K	0.01%	140

Other funds holding BMEA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Nine Masts Capital's BMEA Position: Q2 2026 in Review

Nine Masts Capital sold out of Biomea Fusion (BMEA) in Q2 2026, closing a stake of 32,472 shares — an estimated $49.7K sold.

Nine Masts Capital first reported a position in BMEA in Q1 2026 and held it in 1 quarter. The position peaked at $49.7K in Q1 2026. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

Nine Masts Capital reported no remaining Biomea Fusion position as of Q2 2026 after selling out during the quarter.
Nine Masts Capital sold 32,472 Biomea Fusion shares in Q2 2026, an estimated $49.7K.
Nine Masts Capital first reported a position in Biomea Fusion in Q1 2026 and held it in 1 quarter.
Nine Masts Capital's Biomea Fusion position peaked at $49.7K in Q1 2026.
61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.